An explanation for the enhanced catecholaminergic influence on IL-4 synthesis in patients with RA may be found in an increased inhibitory effect of catecholamines on IL-2 production that decreases IL-4 synthesis indirectly [40,41]. The gene discussed is IL4; the disease is rheumatoid arthritis.